IntelliPharmaCeutics and Vasogen to merge
This article was originally published in Scrip
Executive Summary
IntelliPharmaCeutics (IPC) and Vasogen, two Canadian pharmaceutical companies, are to merge, providing IPC with a listing on Nasdaq and the Toronto Stock Exchange (TSX).